Delivery Order SPE2DB24D3013-SPE2DB26FFFUX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.50 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsules (30-count units). The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,030.14 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units). The contract, executed on October 20, 2025, with an ultimate completion date of October 21, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (30-count units) under a firm fixed-price contract type. The award, issued on September 22, 2025, carries a ceiling value of $1,125.12 and is scheduled for completion by September 23, 2025. This non-set-aside competitive award reflects the contractor's established capability to fulfill federal pharmaceutical procurement requirements through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nexium DR 40 mg capsules (30-count units) valued at $3,942.12, with a firm fixed price and no set-aside designation. The order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nexium DR 20 mg capsules (30-count units) with a ceiling value of $1,687.86. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award of this pharmaceutical supply requirement. The contract is set to complete by September 26, 2025, with performance fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency has awarded a $1,125.04 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Nexium DR 40 mg capsules, with an ultimate completion date of October 24, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Nexium DR 40 mg capsules (30-count units) with a ceiling value of $2,323.45. This firm fixed price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was made through competitive procurement with no set-aside designation,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFUXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Nexium DR 40 mg capsules (90-count units), valued at $1,187.34 under a firm fixed-price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal agencies worldwide. The company's extensive portfolio of federal medical procurement awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for the Department of Defense and related healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/23/25 |